Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tracks ultomiris safety in pregnant women

NCT ID NCT06312644

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 29 times

Summary

This study monitors 75 pregnant or postpartum women who have taken Ultomiris for conditions like PNH or aHUS. Researchers will track pregnancy outcomes and infant health up to one year after birth. The goal is to better understand any risks or complications linked to the drug during pregnancy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANCY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    RECRUITING

    Boston, Massachusetts, 02210, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Research Site

    NOT_YET_RECRUITING

    Melbourne, Victoria, 3050, Australia

    Contact

  • Research Site

    RECRUITING

    Paris, 75475, France

    Contact

  • Research Site

    RECRUITING

    Essen, Norte-Westfalia, D-45147, Germany

    Contact

  • Research Site

    RECRUITING

    Rome, 00168, Italy

    Contact

  • Research Site

    ACTIVE_NOT_RECRUITING

    Seoul, South Korea

  • Research Site

    ACTIVE_NOT_RECRUITING

    London, SE5 9NU, United Kingdom

Conditions

Explore the condition pages connected to this study.